Literature DB >> 140641

Fatty acid composition of lipids in cerebral myelin and synaptosomes in phenylketonuria and Down syndrome.

R C Johnson, C M McKean, S N Shah.   

Abstract

Lipid and fatty acid composition of myelin and synaptosomes isolated from brains of phenylketonuric (PKU) and Down syndrome (DS) patients and patients with neither of these disorders was determined. No differences were observed in the proportions of cholesterol to phospholipids in synaptosomes and cholesterol to galactolipids to phospholipids in myelin or in the fatty acid composition of phospholipids in synaptosomes. However, the myelin from PKU brains contained reduced proportions of unsaturated and long-chain fatty acids. We conclude that genetic PKU and its experimental model have in common a defect in cerebral fatty acid metabolism, and that cerebral lipid abnormalities in this condition, rather than being generalized, may be confined to the glial cell population that synthesizes myelin. We further conclude that DS is not associated with an abnormality of cerebral lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140641     DOI: 10.1001/archneur.1977.00500170042008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1-/-) deficient mouse brain provide additional evidence for myelin alterations.

Authors:  G Barcelo-Coblijn; E J Murphy; K Mills; B Winchester; C Jakobs; O C Snead; K M Gibson
Journal:  Biochim Biophys Acta       Date:  2007-01-04

2.  Fatty acid composition of myelin lipids from developing rat forebrain and spinal cord: influence of experimental hyperphenylalaninaemia.

Authors:  G Huether; M Klapproth; V Neuhoff
Journal:  Neurochem Res       Date:  1986-09       Impact factor: 3.996

3.  Role of the liver in the pathogenesis of cerebral disorders in phenylketonuria.

Authors:  Y I Barashnev; V V Korneichuk; A I Klembovsky; L A Klyushina
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

4.  Phenylketonuria: clinical and experimental considerations revealed by the use of animal models.

Authors:  J D Lane; V Neuhoff
Journal:  Naturwissenschaften       Date:  1980-05

5.  Effects of alpha-methylphenylalanine plus phenylalanine treatment during development on myelin in rat brain.

Authors:  R C Johnson; S N Shah
Journal:  Neurochem Res       Date:  1980-07       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.